Articles dans des revues avec comité de lecture (217)
  1. 144. Delvigne, A., Carlier, C., & Rozenberg, S. (2001). Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle? Fertility and sterility, 76(4), 844-846. doi:10.1016/S0015-0282(01)02007-6
  2. 145. Rozenberg, S. (2001). Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy. European journal of obstetrics, gynecology, and reproductive biology, 94(1), 86-91. doi:10.1016/S0301-2115(00)00301-8
  3. 146. Rozenberg, S., Caubel, P., & Lim, P. (2001). Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: Tolerability and effect on vasomotor symptoms. International journal of gynaecology and obstetrics, 72(3), 235-243. doi:10.1016/S0020-7292(00)00342-8
  4. 147. Lopes, P., Rozenberg, S., De Graaf, J., Fernandez-Villoria, E., & Marianowski, L. (2001). Aerodiol® versus the transdermal route: Perspectives for patient preference. Maturitas, 38(SUPPL.1), S31-S39.
  5. 148. Delvigne, A., & Rozenberg, S. (2001). Preventive attitude of physicians to avoid OHSS in IVF patients. Human reproduction, 16(12), 2491-2495. doi:10.1093/humrep/16.12.2491
  6. 149. Rozenberg, S., Fellemans, C., Kroll, M., Gevers, R., & Vandromme, J. (2001). Place du traitement hormonal de substitution comme prévention de l'ostéoporose chez les femmes âgées. Références en gynécologie obstétrique, 8(1), 55-58.
  7. 150. Rozenberg, S., & Ham, H. (2001). Effect of physicians opinion on patients' choice of treatment. European journal of obstetrics, gynecology, and reproductive biology, 96(2), 215-217. doi:10.1016/S0301-2115(00)00461-9
  8. 151. Rozenberg, S., Ham, H., & Liebens, F. (2001). Screening for breast cancer with mammography. Lancet, 358(9299), 2167-2168. doi:10.1016/S0140-6736(01)07197-5
  9. 152. Ylikorkala, O., & Rozenberg, S. (2000). Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women. Maturitas, 37(2), 83-93. doi:10.1016/S0378-5122(00)00155-9
  10. 153. Rozenberg, S., Carly, B., Liebens, F., & Ham, H. (2000). Effect of screening programme on mortality from breast cancer. Women might not accept mammography if benefit is lower than is currently thought. BMJ. British medical journal, 321(7275), 1527-1528.
  11. 154. Rozenberg, S., Ham, H., & Liebens, F. (2000). Screening mammography in elderly women. Research on Breast Cancer in Older Women Consortium. JAMA (Chicago, Ill.), 283(24), 3203; author reply 3204.
  12. 155. Rozenberg, S., Twagirayezu, P., Paesmans, M., & Ham, H. (2000). Health perception by women who work in a medical environment. Maturitas, 35(2), 119-124. doi:10.1016/S0378-5122(00)00122-5
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>